SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001144204-19-007224
Filing Date
2019-02-13
Accepted
2019-02-13 16:29:16
Documents
1
Group Members
BAKER BROS. ADVISORS (GP) LLCFELIX J. BAKERJULIAN C. BAKER

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tv511634_sc13ga.htm SC 13G/A 94922
  Complete submission text file 0001144204-19-007224.txt   96854
Mailing Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087
Business Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087 610-254-4201
Aevi Genomic Medicine, Inc. (Subject) CIK: 0001138776 (see all company filings)

IRS No.: 980217544 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86182 | Film No.: 19597667
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014 2123395600
BAKER BROS. ADVISORS LP (Filed by) CIK: 0001263508 (see all company filings)

IRS No.: 134093645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A